Bristol-Myers Squibb News and Activities

Presence

Bristol-Myers Squibb is a global biopharmaceutical company that focuses on discovering, developing, and delivering innovative medicines for patients with serious diseases. Their products target a wide range of medical conditions in areas such as oncology, cardiovascular, immunoscience, and fibrotic diseases.

Oncology
Cardiovascular
Immunoscience
Fibrotic Diseases

2024 Revenue: Approximately $45 billion

Employees: 30,000

Bristol-Myers Squibb is one of the...

Bristol-Myers Squibb is a company listed under the stock ticker BMY (US).

Bristol-Myers Squibb has a direct presence in 21 countries.

Bristol-Myers Squibb has 23 subsidiaries including Bristol-Myers Squibb APAC, Bristol-Myers Squibb Australia and Bristol-Myers Squibb Benelux.

They are in:

Pharmaceuticals83%
Biotechnology17%

Acquisition, funding and merger involving Bristol-Myers Squibb.

Bristol-Myers Squibb has announced the acquisition of 2Seventy Bio (posted on March 11 2025).
Bristol-Myers Squibb has announced the acquisition of Karuna Therapeutics (posted on December 22 2023).
Bristol-Myers Squibb has announced the acquisition of Mirati (posted on October 12 2023).

Executives

View the org chart displaying its 180 main executives

Most searched biographies at Bristol-Myers Squibb

Popular executive movements at Bristol-Myers Squibb

Sandra Leung, Executive Vice President and General Counsel, has left the company (posted on May 6 2025).
Cari Gallman, who was Executive Vice President, Corporate Affairs, is promoted to Executive Vice President, General Counsel and Chief Policy Officer (posted on May 6 2025).

Create your alert
to follow the executive moves at Bristol-Myers Squibb.